Michael Gelband’s PLDT PHI Stock Holding History

Michael Gelband’s Portfolio PHI Stock Details PHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,981	Closed	-$270K	–	2292
2020 Q3	$270K	Buy	+9,981	New	+$278K	0.01%	1332

Other funds holding PHI

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Michael Gelband's PHI Position: Q4 2020 in Review

Michael Gelband sold out of PLDT (PHI) in Q4 2020, closing a stake of 9,981 shares — an estimated $270K sold.

Michael Gelband first reported a position in PHI in Q3 2020 and held it in 1 quarter. The position peaked at $270K in Q3 2020. 69 funds tracked by Wall St. Rank hold PHI as of Q4 2020.

Michael Gelband reported no remaining PLDT position as of Q4 2020 after selling out during the quarter.
Michael Gelband sold 9,981 PLDT shares in Q4 2020, an estimated $270K.
Michael Gelband first reported a position in PLDT in Q3 2020 and held it in 1 quarter.
Michael Gelband's PLDT position peaked at $270K in Q3 2020.
69 funds tracked by Wall St. Rank held PLDT as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.